Miller Mary

Miller Mary is listed in filings as Chief Legal Officer at Acrivon Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 20, 2026, including 22 public disclosures. Recent filings connect the profile to Acrivon Therapeutics, Inc. Common Stock (ACRV). The current snapshot covers public activity from Jul 19, 2024 to May 20, 2026. Reported amounts are shown as $353 to $195.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.